StockData
Immuron Ltd logo

Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.88−0.03 (-3.52%)

Close on Nov 13, 2026Market cap $7.06MP/E –Yield –

Immuron total assets

Total assets on the balance sheet at the end of each period.

Immuron's total assets was A$13.15M at Jun 30, 2026. For fiscal 2026 it was A$13.15M, up 29.8% from the year before. Over ten years it grew 4.1% a year on average. The highest annual figure on record is A$27.05M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026A$13.15M+29.8%
FY2025Jun 30, 2025A$10.13M-34.9%
FY2024Jun 30, 2024A$15.55M-29.3%
FY2023Jun 30, 2023A$21.99M-11.5%
FY2022Jun 30, 2022A$24.86M-8.1%
FY2021Jun 30, 2021A$27.05M+336.2%
FY2020Jun 30, 2020A$6.20M-27.6%
FY2019Jun 30, 2019A$8.56M-7.4%
FY2018Jun 30, 2018A$9.24M+11.5%
FY2017Jun 30, 2017A$8.29M-6.1%
FY2016Jun 30, 2016A$8.83M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026A$13.15M-47.1%
Q4 FY2025CQ2 2025Jun 30, 2025A$10.13M-62.6%
Q4 FY2024CQ2 2024Jun 30, 2024A$15.55M+150.7%
Q4 FY2023CQ2 2023Jun 30, 2023A$21.99M+156.8%
Q4 FY2022CQ2 2022Jun 30, 2022A$24.86M+168.9%
Q4 FY2021CQ2 2021Jun 30, 2021A$27.05M+226.5%
Q4 FY2020CQ2 2020Jun 30, 2020A$6.20M-29.7%
Q4 FY2019CQ2 2019Jun 30, 2019A$8.56M–
Q4 FY2018CQ2 2018Jun 30, 2018A$9.24M–
Q4 FY2017CQ2 2017Jun 30, 2017A$8.29M–
Q4 FY2016CQ2 2016Jun 30, 2016A$8.83M–

More Immuron figures

See a number that looks wrong?